281 related articles for article (PubMed ID: 6713900)
1. Epidemiology of aluminium toxicity in a 'low incidence' area.
Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
[No Abstract] [Full Text] [Related]
2. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
[No Abstract] [Full Text] [Related]
3. Therapy of aluminium overload (II).
Ackrill P; Day JP
Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
[No Abstract] [Full Text] [Related]
4. Prophylaxis and methods for early recognition of aluminium intoxication.
Fuchs C; Armstrong VW; Quellhorst E; Scheler F
Contrib Nephrol; 1984; 38():81-94. PubMed ID: 6713903
[No Abstract] [Full Text] [Related]
5. Therapy of aluminum overload (I).
Pierides AM; Myli MP
Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
[No Abstract] [Full Text] [Related]
6. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
Nielsen LP; Heaf JG
Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
[No Abstract] [Full Text] [Related]
7. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
[No Abstract] [Full Text] [Related]
8. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
[No Abstract] [Full Text] [Related]
9. What is the value of plasma/serum aluminum in patients with chronic renal failure?
Winney RJ; Cowie JF; Robson JS
Clin Nephrol; 1985; 24 Suppl 1():S2-8. PubMed ID: 3842104
[TBL] [Abstract][Full Text] [Related]
10. [Causes of hyperaluminemia in patients maintained on hemodialysis].
Balezina OA; Ermolenko VM; Bel'skii NK; Nebol'sina LA; Segel'man VS
Ter Arkh; 1982; 54(7):85-6. PubMed ID: 7135231
[No Abstract] [Full Text] [Related]
11. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
Winney RJ; Cowie JF; Robson JS
Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
[No Abstract] [Full Text] [Related]
12. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Mudde AH; Roodvoets AP; Van Groningen K
Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
[No Abstract] [Full Text] [Related]
13. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
[No Abstract] [Full Text] [Related]
14. Aluminum osteopathy.
Cournot-Witmer G
Contrib Nephrol; 1984; 38():59-64. PubMed ID: 6713901
[No Abstract] [Full Text] [Related]
15. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
[TBL] [Abstract][Full Text] [Related]
16. Hyperaluminemia in renal failure: the influence of age and citrate intake.
Bakir AA; Hryhorczuk DO; Ahmed S; Hessl SM; Levy PS; Spengler R; Dunea G
Clin Nephrol; 1989 Jan; 31(1):40-4. PubMed ID: 2914409
[TBL] [Abstract][Full Text] [Related]
17. Risk of orally administered aluminium hydroxide and results of withdrawal.
Bournerias F; Monnier N; Reveillaud RJ
Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
[TBL] [Abstract][Full Text] [Related]
18. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
Wills MR; Savory J
Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
[No Abstract] [Full Text] [Related]
19. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
Wills MR; Savory J
Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Andress DL; Endres DB; Ott SM; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
